| Name | Title | Type |
|---|---|---|
| Roxanne Page | SHAREHOLDER | Auditee |
| Jim Primus | CHIEF FINANCIAL OFFICER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 20389 | 2022 | 2022-12-01 | Doeren Mayhew & CO PC | $2.12M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 20389 | 2022 | 2022-12-01 | 592966 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592965 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592964 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592963 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592962 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592961 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592960 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592959 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592958 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592957 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592956 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592955 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592954 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592953 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592952 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592951 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592950 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592949 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 592948 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 592947 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 592946 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16524 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16523 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16522 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16521 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16520 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16519 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16518 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16517 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16516 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16515 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16514 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16513 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16512 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16511 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16510 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16509 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16508 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16507 | 2022-002 | Material Weakness | Yes | P |
| 20389 | 2022 | 2022-12-01 | 16506 | 2022-004 | - | - | I |
| 20389 | 2022 | 2022-12-01 | 16505 | 2022-003 | Significant Deficiency | - | L |
| 20389 | 2022 | 2022-12-01 | 16504 | 2022-002 | Material Weakness | Yes | P |